Semler Scientific (SMLR) 1.8000 $SMLR Semler Sc
Post# of 273254
Posted On: 09/22/2016 7:13:01 AM
Semler Scientific (SMLR) 1.8000 $SMLR
Semler Scientific, Inc. To Begin Trading on OTCQB®
PR Newswire - Thu Aug 11, 3:18PM CDT
Semler Scientific, Inc. (OTCQB: SMLR; "Semler"
, an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, announced today that its common stock will be delisted from the NASDAQ Capital Market and that suspension of trading in the shares was effective at the open of business on August 11, 2016 for failure to regain compliance with the required $2,500,000 minimum stockholders' equity for continued listing within the compliance periods afforded by the NASDAQ's hearings panel.
Semler Reports Second Quarter and Year-to-date 2016 Financial Results
PR Newswire - Fri Jul 29, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today reported financial results for the second quarter and year-to-date ended June 30, 2016.
Semler Reports 2016 First Quarter Financial Results
PR Newswire - Fri Apr 29, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today reported financial results for the first quarter ended March 31, 2016.
Semler to Report First Quarter 2016 Financial Results and Host Conference Call on April 29, 2016
PR Newswire - Wed Apr 20, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today announced that it will report first quarter 2016 financial results before the open of U.S. financial markets on April 29, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Semler to Report Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on February 19, 2016
PR Newswire - Tue Feb 09, 7:03AM CST
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today announced that it will report fourth quarter and full year 2015 financial results before the open of U.S. financial markets on February 19, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Semler Scientific to Present at the LD Micro Main Event
PR Newswire - Mon Nov 16, 9:03AM CST
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today announced that it will be presenting at the 8th annual LD Micro Main Event on Thursday, December 3rd at 9:00 AM PST / 12:00 PM EST. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will be giving the presentation. The presentation will be webcast live and may be accessed using this link: http://wsw.com/webcast/ldmicro9/smlr. The webcast will be archived for 90 days following the live presentation.
Semler Reports Third Quarter 2015 Financial Results
PR Newswire - Fri Oct 30, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the third quarter ended September 30, 2015.
Semler's net loss widens to USD1.3m in Q2 2015
M2 - Mon Aug 03, 5:44AM CDT
Diagnostic company Semler Scientific (NasdaqCM:SMLR) disclosed on Friday that it recorded a net loss of USD1.3m (USD0.27 per share) for the second quarter ended 30 June 2015.
Semler Reports Second Quarter 2015 Financial Results
PR Newswire - Fri Jul 31, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the second quarter ended June 30, 2015.
Semler to Report Second Quarter 2015 Financial Results and Host Conference Call on July 31, 2015
PR Newswire - Mon Jul 20, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced that it will report second quarter 2015 financial results before the open of U.S. financial markets on July 31, 2015. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Semler Reports First Quarter 2015 Financial Results
PR Newswire - Fri May 01, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today reported financial results for the first quarter ended March 31, 2015.
Semler Adds Top Insurance Plan to Customer List
PR Newswire - Tue Apr 28, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced that it has received an order from another one of the largest 15 insurance plans in the country who offer Medicare Advantage programs. This brings the total count to four of the top 15 insurance plans who are now customers of Semler.
Semler to Report First Quarter 2015 Financial Results and Host Conference Call on May 1, 2015
PR Newswire - Thu Apr 23, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced that it will report first quarter 2014 financial results before the open of U.S. financial markets on May 1, 2015. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET on May 1, 2015.
Semler Launches WellChec(TM) Platform
PR Newswire - Wed Apr 01, 7:07AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced the launch of its multi-test platform, WellChec(TM), to perform risk assessments for the healthcare insurance industry.
Semler awarded US FDA approval for next generation PAD testing system
M2 - Fri Mar 20, 7:49AM CDT
Medical risk assessment company Semler Scientific (NasdaqCM:SMLR) revealed on Thursday that it has received the US Food and Drug Administration's 510(k) marketing clearance for its next generation peripheral artery disease (PAD) testing system.
Semler Scientific, Inc. To Begin Trading on OTCQB®
PR Newswire - Thu Aug 11, 3:18PM CDT
Semler Scientific, Inc. (OTCQB: SMLR; "Semler"
, an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, announced today that its common stock will be delisted from the NASDAQ Capital Market and that suspension of trading in the shares was effective at the open of business on August 11, 2016 for failure to regain compliance with the required $2,500,000 minimum stockholders' equity for continued listing within the compliance periods afforded by the NASDAQ's hearings panel. Semler Reports Second Quarter and Year-to-date 2016 Financial Results
PR Newswire - Fri Jul 29, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today reported financial results for the second quarter and year-to-date ended June 30, 2016.
Semler Reports 2016 First Quarter Financial Results
PR Newswire - Fri Apr 29, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today reported financial results for the first quarter ended March 31, 2016.
Semler to Report First Quarter 2016 Financial Results and Host Conference Call on April 29, 2016
PR Newswire - Wed Apr 20, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today announced that it will report first quarter 2016 financial results before the open of U.S. financial markets on April 29, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Semler to Report Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on February 19, 2016
PR Newswire - Tue Feb 09, 7:03AM CST
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging growth company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare insurers and physician groups, today announced that it will report fourth quarter and full year 2015 financial results before the open of U.S. financial markets on February 19, 2016. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Semler Scientific to Present at the LD Micro Main Event
PR Newswire - Mon Nov 16, 9:03AM CST
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today announced that it will be presenting at the 8th annual LD Micro Main Event on Thursday, December 3rd at 9:00 AM PST / 12:00 PM EST. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will be giving the presentation. The presentation will be webcast live and may be accessed using this link: http://wsw.com/webcast/ldmicro9/smlr. The webcast will be archived for 90 days following the live presentation.
Semler Reports Third Quarter 2015 Financial Results
PR Newswire - Fri Oct 30, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the third quarter ended September 30, 2015.
Semler's net loss widens to USD1.3m in Q2 2015
M2 - Mon Aug 03, 5:44AM CDT
Diagnostic company Semler Scientific (NasdaqCM:SMLR) disclosed on Friday that it recorded a net loss of USD1.3m (USD0.27 per share) for the second quarter ended 30 June 2015.
Semler Reports Second Quarter 2015 Financial Results
PR Newswire - Fri Jul 31, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the second quarter ended June 30, 2015.
Semler to Report Second Quarter 2015 Financial Results and Host Conference Call on July 31, 2015
PR Newswire - Mon Jul 20, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced that it will report second quarter 2015 financial results before the open of U.S. financial markets on July 31, 2015. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET the same day.
Semler Reports First Quarter 2015 Financial Results
PR Newswire - Fri May 01, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today reported financial results for the first quarter ended March 31, 2015.
Semler Adds Top Insurance Plan to Customer List
PR Newswire - Tue Apr 28, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced that it has received an order from another one of the largest 15 insurance plans in the country who offer Medicare Advantage programs. This brings the total count to four of the top 15 insurance plans who are now customers of Semler.
Semler to Report First Quarter 2015 Financial Results and Host Conference Call on May 1, 2015
PR Newswire - Thu Apr 23, 7:03AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced that it will report first quarter 2014 financial results before the open of U.S. financial markets on May 1, 2015. Doug Murphy-Chutorian, M.D., chief executive officer of Semler, will host a conference call at 11 a.m. ET on May 1, 2015.
Semler Launches WellChec(TM) Platform
PR Newswire - Wed Apr 01, 7:07AM CDT
Semler Scientific, Inc. (Nasdaq: SMLR), an emerging medical risk assessment company that develops, manufactures and markets patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today announced the launch of its multi-test platform, WellChec(TM), to perform risk assessments for the healthcare insurance industry.
Semler awarded US FDA approval for next generation PAD testing system
M2 - Fri Mar 20, 7:49AM CDT
Medical risk assessment company Semler Scientific (NasdaqCM:SMLR) revealed on Thursday that it has received the US Food and Drug Administration's 510(k) marketing clearance for its next generation peripheral artery disease (PAD) testing system.
(0)
(0)Scroll down for more posts ▼